These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21745498)

  • 41. Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?
    Whitaker KD; Sheth D; Olopade OI
    Breast Cancer Res Treat; 2020 Sep; 183(2):243-250. PubMed ID: 32621252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
    Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans DG; Gilbert FJ; Hawnaur J; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Potterton J; Thompson D; Turnbull LW; Walker LG; Warren R; Leach MO;
    Br J Cancer; 2006 Oct; 95(7):801-10. PubMed ID: 17016484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Choices for women at risk of hereditary breast cancer].
    Saadatmand S; Obdeijn IM; Koppert LB; Tilanus-Linthorst M
    Ned Tijdschr Geneeskd; 2013; 157(43):A6625. PubMed ID: 24152366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evidence base for breast cancer screening.
    Glasziou P; Houssami N
    Prev Med; 2011 Sep; 53(3):100-2. PubMed ID: 21658406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.
    Phi XA; Houssami N; Obdeijn IM; Warner E; Sardanelli F; Leach MO; Riedl CC; Trop I; Tilanus-Linthorst MM; Mandel R; Santoro F; Kwan-Lim G; Helbich TH; de Koning HJ; Van den Heuvel ER; de Bock GH
    J Clin Oncol; 2015 Feb; 33(4):349-56. PubMed ID: 25534390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in
    Guindalini RSC; Zheng Y; Abe H; Whitaker K; Yoshimatsu TF; Walsh T; Schacht D; Kulkarni K; Sheth D; Verp MS; Bradbury AR; Churpek J; Obeid E; Mueller J; Khramtsova G; Liu F; Raoul A; Cao H; Romero IL; Hong S; Livingston R; Jaskowiak N; Wang X; Debiasi M; Pritchard CC; King MC; Karczmar G; Newstead GM; Huo D; Olopade OI
    Clin Cancer Res; 2019 Mar; 25(6):1786-1794. PubMed ID: 30154229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma.
    Ng AK; Garber JE; Diller LR; Birdwell RL; Feng Y; Neuberg DS; Silver B; Fisher DC; Marcus KJ; Mauch PM
    J Clin Oncol; 2013 Jun; 31(18):2282-8. PubMed ID: 23610104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer.
    Liljegren A; von Wachenfeldt A; Azavedo E; Eloranta S; Grundström H; Ståhlbom AK; Sundbom A; Sundén P; Svane G; Ulitzsch D; Arver B
    Breast Cancer Res Treat; 2018 Apr; 168(3):655-666. PubMed ID: 29318406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer screening in developing countries.
    Mittra I
    Prev Med; 2011 Sep; 53(3):121-2. PubMed ID: 21712052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overdiagnosis in breast cancer: design and methods of estimation in observational studies.
    Puliti D; Miccinesi G; Paci E
    Prev Med; 2011 Sep; 53(3):131-3. PubMed ID: 21658405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of advances in treatment on the efficacy of mammography screening.
    Jatoi I
    Prev Med; 2011 Sep; 53(3):103-4. PubMed ID: 21722664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evolving role of new imaging methods in breast screening.
    Houssami N; Ciatto S
    Prev Med; 2011 Sep; 53(3):123-6. PubMed ID: 21605590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population studies of the effectiveness of mammographic screening.
    Coldman A; Phillips N
    Prev Med; 2011 Sep; 53(3):115-7. PubMed ID: 21798279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.
    Gilbert FJ; Warren RM; Kwan-Lim G; Thompson DJ; Eeles RA; Evans DG; Leach MO;
    Radiology; 2009 Aug; 252(2):358-68. PubMed ID: 19703879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI breast screening in high-risk women: cancer detection and survival analysis.
    Evans DG; Kesavan N; Lim Y; Gadde S; Hurley E; Massat NJ; Maxwell AJ; Ingham S; Eeles R; Leach MO; ; Howell A; Duffy SW
    Breast Cancer Res Treat; 2014 Jun; 145(3):663-72. PubMed ID: 24687378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
    Ozanne EM; Drohan B; Bosinoff P; Semine A; Jellinek M; Cronin C; Millham F; Dowd D; Rourke T; Block C; Hughes KS
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):146-9. PubMed ID: 23093547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.
    Murphy CD; Lee JM; Drohan B; Euhus DM; Kopans DB; Gadd MA; Rafferty EA; Specht MC; Smith BL; Hughes KS
    Cancer; 2008 Dec; 113(11):3116-20. PubMed ID: 18932252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Staging, risk assessment and screening of breast cancer.
    Yalcin B
    Exp Oncol; 2013 Dec; 35(4):238-45. PubMed ID: 24382431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.
    Lowry KP; Lee JM; Kong CY; McMahon PM; Gilmore ME; Cott Chubiz JE; Pisano ED; Gatsonis C; Ryan PD; Ozanne EM; Gazelle GS
    Cancer; 2012 Apr; 118(8):2021-30. PubMed ID: 21935911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening, imaging, and image-guided biopsy techniques for breast cancer.
    Smetherman DH
    Surg Clin North Am; 2013 Apr; 93(2):309-27. PubMed ID: 23464688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.